Surgery Partners Q3 Adj EPS $0.19 Beats $0.16 Estimate, Sales $674.10M Beat $672.27M Estimate
Portfolio Pulse from Benzinga Newsdesk
Surgery Partners reported Q3 adjusted earnings of $0.19 per share, beating the analyst consensus estimate of $0.16 by 18.75%. This is a 1050% increase over losses from the same period last year. The company also reported quarterly sales of $674.10 million, beating the analyst consensus estimate of $672.27 million by 0.27%. This is an 8.62% increase over sales from the same period last year.
November 07, 2023 | 12:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Surgery Partners reported strong Q3 results, beating both earnings and sales estimates. This could lead to a positive market reaction.
Surgery Partners reported a significant increase in earnings and sales compared to the same period last year, beating analyst estimates. This positive financial performance is likely to be viewed favorably by investors, potentially leading to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100